Market research
PRTO Tidal Trust III
NYSE USD Other
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- 0.0%
- Beta
- 0.0
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Other
- Industry
- Other
- ISIN
- US74365U1079
- Market cap
- 19M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- 0.0%
- Beta
- 0.0
About
About Tidal Trust III
The fund, an actively-managed exchange-traded fund ("ETF"), seeks to achieve its investment objective by dynamically allocating across multiple asset classes based on systematic trend-following and momentum-driven signals. Under normal market conditions, allocation to the equity asset class is approximately 70% of the fund"s net assets.
Research context
Tidal Trust III appears in PyInvesting’s ETF catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Other
- Industry
- Other
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PRTO discussion.
5 years, 6 months ago
Proteon Therapeutics, Inc is currently in a long term downtrend where the price is trading 17.2% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Based on the above factors, Proteon Therapeutics, Inc gets an overall score of 1/5.